$VSTM
Verastem, Inc. Stock $vstm

$vstm Overview Financials Valuation SEC Filings Company Website

2013 Q3 Form 10-Q Financial Statement

#000104746913008394 Filed on August 13, 2013

Income Statement

Concept	2013 Q3	2013 Q2	2012 Q2
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$3.860M	$4.240M	$2.210M
YoY Change	67.83%	91.86%	190.79%
% of Gross Profit
Research & Development	$6.789M	$6.045M	$4.683M
YoY Change	-16.52%	29.08%	171.32%
% of Gross Profit
Depreciation & Amortization	$60.00K	$50.00K	$40.00K
YoY Change	0.0%	25.0%	300.0%
% of Gross Profit
Operating Expenses	$10.64M	$10.28M	$6.896M
YoY Change	2.05%	49.13%	177.51%
Operating Profit	-$10.64M	-$10.28M	-$6.896M
YoY Change	2.05%	49.13%	177.51%
Interest Expense	$50.00K	$30.00K	$70.00K
YoY Change	-16.67%	-57.14%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$10.59M	-$10.25M	-$6.830M
YoY Change	2.12%	50.07%	174.3%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$10.59M	-$10.25M	-$6.825M
YoY Change	2.16%	50.18%	174.65%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$471.9K	-$494.5K	-$343.9K
COMMON SHARES
Basic Shares Outstanding	25.59M shares	21.29M shares	21.06M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2013 Q3	2013 Q2	2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$99.90M	$57.50M	$38.70M
YoY Change	113.01%	48.58%
Cash & Equivalents	$22.64M	$13.88M	$15.75M
Short-Term Investments	$77.30M	$43.60M	$22.90M
Other Short-Term Assets	$1.100M	$800.0K	$400.0K
YoY Change	266.67%	100.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$101.0M	$58.29M	$39.20M
YoY Change	113.63%	48.7%
LONG-TERM ASSETS
Property, Plant & Equipment	$674.0K	$730.0K	$800.0K
YoY Change	-23.76%	-8.75%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$30.30M	$20.60M	$65.60M
YoY Change	-40.12%	-68.6%
Other Assets	$322.0K	$295.0K	$100.0K
YoY Change	222.0%	195.0%
Total Long-Term Assets	$31.42M	$21.67M	$66.50M
YoY Change	-39.04%	-67.42%
TOTAL ASSETS
Total Short-Term Assets	$101.0M	$58.29M	$39.20M
Total Long-Term Assets	$31.42M	$21.67M	$66.50M
Total Assets	$132.4M	$79.96M	$105.7M
YoY Change	34.0%	-24.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.836M	$2.034M	$2.500M
YoY Change	5.7%	-18.64%
Accrued Expenses	$3.457M	$2.354M	$763.0K
YoY Change	144.83%	208.52%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.706M	$5.238M	$3.200M
YoY Change	81.2%	63.69%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$18.00K	$0.00	$100.0K
YoY Change	-82.0%	-100.0%
Total Long-Term Liabilities	$18.00K	$0.00	$100.0K
YoY Change	-82.0%	-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.706M	$5.238M	$3.200M
Total Long-Term Liabilities	$18.00K	$0.00	$100.0K
Total Liabilities	$5.724M	$5.300M	$3.300M
YoY Change	78.88%	60.61%
SHAREHOLDERS EQUITY
Retained Earnings	-$76.33M	-$65.74M
YoY Change	98.1%
Common Stock	$3.000K	$2.000K
YoY Change	50.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$126.7M	$74.69M	$102.4M
YoY Change
Total Liabilities & Shareholders Equity	$132.4M	$79.96M	$105.7M
YoY Change	34.0%	-24.35%

Cashflow Statement

Concept	2013 Q3	2013 Q2	2012 Q2
OPERATING ACTIVITIES
Net Income	-$10.59M	-$10.25M	-$6.825M
YoY Change	2.16%	50.18%	174.65%
Depreciation, Depletion And Amortization	$60.00K	$50.00K	$40.00K
YoY Change	0.0%	25.0%	300.0%
Cash From Operating Activities	-$7.100M	-$6.320M	-$5.040M
YoY Change	5.34%	25.4%	3050.0%
INVESTING ACTIVITIES
Capital Expenditures	-$10.00K	-$30.00K	-$40.00K
YoY Change	-93.33%	-25.0%	-89.74%
Acquisitions
YoY Change
Other Investing Activities	-$43.42M	-$7.980M	-$4.630M
YoY Change	-2021.24%	72.35%	5044.44%
Cash From Investing Activities	-$43.43M	-$8.010M	-$4.670M
YoY Change	-2158.29%	71.52%	893.62%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	59.29M	-30.00K	0.000
YoY Change			-100.0%
NET CHANGE
Cash From Operating Activities	-7.100M	-6.320M	-5.040M
Cash From Investing Activities	-43.43M	-8.010M	-4.670M
Cash From Financing Activities	59.29M	-30.00K	0.000
Net Change In Cash	8.760M	-14.36M	-9.710M
YoY Change	-289.2%	47.89%	-184.88%
FREE CASH FLOW
Cash From Operating Activities	-$7.100M	-$6.320M	-$5.040M
Capital Expenditures	-$10.00K	-$30.00K	-$40.00K
Free Cash Flow	-$7.090M	-$6.290M	-$5.000M
YoY Change	7.59%	25.8%	-2273.91%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2012Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	81400000	USD
	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0	USD
CY2013Q2	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0	USD
CY2012Q2	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0	USD
CY2013Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-65738000	USD
CY2013Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	79961000	USD
	dei	Entity Central Index Key EntityCentralIndexKey	0001526119
	dei	Document Type DocumentType	10-Q
	dei	Document Period End Date DocumentPeriodEndDate	2013-06-30
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2013Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	25593992	shares
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
CY2013Q2	us-gaap	Short Term Investments ShortTermInvestments	43571000	USD
CY2013Q2	us-gaap	Common Stock Value CommonStockValue	2000	USD
CY2013Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	140430000	USD
CY2013Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2013Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20364000	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20364000	shares
CY2012Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4683000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11341000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	10096000	USD
CY2012Q4	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	28000	USD
CY2012Q4	us-gaap	Available For Sale Securities Gross Unrealized Losses1 AvailableForSaleSecuritiesGrossUnrealizedLosses1	4000	USD
CY2012Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	91496000	USD
CY2012Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	91520000	USD
	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0	USD
	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0	USD
CY2012Q2	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	0	USD
CY2013Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	0	USD
CY2013Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	670000	USD
CY2012Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	173000	USD
CY2012Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	183000	USD
CY2013Q2	vstm	Contract Research Organizations Current ContractResearchOrganizationsCurrent	942000	USD
CY2012Q4	vstm	Contract Research Organizations Current ContractResearchOrganizationsCurrent	69000	USD
CY2013Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	385000	USD
CY2013Q2	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	13880000	USD
CY2013Q2	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	64132000	USD
CY2013Q2	us-gaap	Available For Sale Securities Gross Unrealized Losses1 AvailableForSaleSecuritiesGrossUnrealizedLosses1	13000	USD
CY2013Q2	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	10000	USD
CY2013Q2	us-gaap	Available For Sale Securities Fair Value Disclosure AvailableForSaleSecuritiesFairValueDisclosure	64129000	USD
CY2013Q2	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	78012000	USD
CY2013Q2	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	78009000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10096000	USD
CY2012Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	54000	USD
CY2013Q2	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	41000	USD
CY2012Q4	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	36000	USD
CY2012Q4	vstm	Accrued Consulting AccruedConsulting	36000	USD
CY2013Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2354000	USD
CY2012Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	551000	USD
	dei	Entity Registrant Name EntityRegistrantName	Verastem, Inc.
CY2012Q4	us-gaap	Short Term Investments ShortTermInvestments	46480000	USD
CY2013Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	841000	USD
CY2012Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	506000	USD
CY2013Q2	us-gaap	Assets Current AssetsCurrent	58292000	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	57082000	USD
CY2013Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	730000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	811000	USD
CY2013Q2	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	20558000	USD
CY2012Q4	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	34944000	USD
CY2013Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	86000	USD
CY2012Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	86000	USD
CY2013Q2	us-gaap	Assets Assets	79961000	USD
CY2012Q4	us-gaap	Assets Assets	92923000	USD
CY2013Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2034000	USD
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1848000	USD
CY2013Q2	us-gaap	Deferred Compensation Share Based Arrangements Liability Current DeferredCompensationShareBasedArrangementsLiabilityCurrent	850000	USD
CY2013Q2	us-gaap	Liabilities Current LiabilitiesCurrent	5238000	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2399000	USD
CY2013Q2	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	16000	USD
CY2012Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	38000	USD
CY2013Q2	us-gaap	Employee Stock Ownership Plan Esop Fair Value Of Shares Subject To Repurchase Obligation EmployeeStockOwnershipPlanESOPFairValueOfSharesSubjectToRepurchaseObligation	16000	USD
CY2012Q4	us-gaap	Employee Stock Ownership Plan Esop Fair Value Of Shares Subject To Repurchase Obligation EmployeeStockOwnershipPlanESOPFairValueOfSharesSubjectToRepurchaseObligation	20000	USD
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	2000	USD
CY2012Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	136893000	USD
CY2013Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3000	USD
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	22000	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-46451000	USD
CY2013Q2	us-gaap	Stockholders Equity StockholdersEquity	74691000	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	90466000	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	92923000	USD
CY2013Q2	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2013Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2012Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2013Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2013Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20794000	shares
CY2013Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20794000	shares
CY2013Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6045000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9486000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	43336000	USD
CY2013Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4239000	USD
CY2012Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2213000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8024000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4338000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	22741000	USD
CY2013Q2	us-gaap	Operating Expenses OperatingExpenses	10284000	USD
CY2012Q2	us-gaap	Operating Expenses OperatingExpenses	6896000	USD
	us-gaap	Operating Expenses OperatingExpenses	19365000	USD
	us-gaap	Operating Expenses OperatingExpenses	13824000	USD
	us-gaap	Operating Expenses OperatingExpenses	66077000	USD
CY2013Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-10284000	USD
CY2012Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-6896000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-19365000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-13824000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-66077000	USD
CY2013Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	34000	USD
CY2012Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	71000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	78000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	128000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	339000	USD
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	-10250000	USD
CY2012Q2	us-gaap	Net Income Loss NetIncomeLoss	-6825000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-19287000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-13696000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-65738000	USD
	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	40000	USD
CY2013Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10250000	USD
CY2012Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6825000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-19287000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13702000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-65778000	USD
CY2013Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.49
CY2012Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.34
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.94
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.79
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-6.20
CY2013Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	20729000	shares
CY2012Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	19863000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	20607000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	17278000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	10608000	shares
CY2013Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10271000	USD
CY2012Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6791000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-19312000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13705000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-65741000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	112000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	94000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	402000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	5182000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	3012000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	14269000	USD
	vstm	Issuance Of Common Stock In Exchange For License IssuanceOfCommonStockInExchangeForLicense	2003000	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	439000	USD
	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	431000	USD
	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	398000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	630000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	379000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1136000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	186000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	177000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2034000	USD
	vstm	Increase Decrease In Accrued Liabilities And Deferred Rent IncreaseDecreaseInAccruedLiabilitiesAndDeferredRent	1781000	USD
	vstm	Increase Decrease In Accrued Liabilities And Deferred Rent IncreaseDecreaseInAccruedLiabilitiesAndDeferredRent	420000	USD
	vstm	Increase Decrease In Accrued Liabilities And Deferred Rent IncreaseDecreaseInAccruedLiabilitiesAndDeferredRent	2370000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-12656000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-9941000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-44959000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	167000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1134000	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	44209000	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	116923000	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	234088000	USD
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	61479000	USD
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	64229000	USD
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	169958000	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	86000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	17239000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-52861000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-65350000	USD
	us-gaap	Proceeds From Issuance Of Redeemable Convertible Preferred Stock ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock	68107000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	30000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	33000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	57599000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	56878000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	124189000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-5203000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	13880000	USD
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	68148000	USD
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	68148000	USD
	us-gaap	Stock Issued1 StockIssued1	837000	USD
	us-gaap	Stock Issued1 StockIssued1	837000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	20954000	USD
CY2012Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15751000	USD
CY2013Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	295000	USD
	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	6000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	31000	USD

Files In Submission

Name	View Source	Status
0001047469-13-008394-index-headers.html	Edgar Link	pending
0001047469-13-008394-index.html	Edgar Link	pending
0001047469-13-008394.txt	Edgar Link	pending
0001047469-13-008394-xbrl.zip	Edgar Link	pending
a2216178z10-q.htm	Edgar Link	pending
a2216178zex-10_2.htm	Edgar Link	pending
a2216178zex-31_1.htm	Edgar Link	pending
a2216178zex-31_2.htm	Edgar Link	pending
a2216178zex-32_1.htm	Edgar Link	pending
a2216178zex-32_2.htm	Edgar Link	pending
a2216178zex-99_1.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
g137071kgi001.jpg	Edgar Link	pending
g137071mm01i001.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R1.xml	Edgar Link	unprocessable
R10.htm	Edgar Link	pending
R10.xml	Edgar Link	unprocessable
R11.htm	Edgar Link	pending
R11.xml	Edgar Link	unprocessable
R12.htm	Edgar Link	pending
R12.xml	Edgar Link	unprocessable
R13.htm	Edgar Link	pending
R13.xml	Edgar Link	unprocessable
R14.htm	Edgar Link	pending
R14.xml	Edgar Link	unprocessable
R15.htm	Edgar Link	pending
R15.xml	Edgar Link	unprocessable
R16.htm	Edgar Link	pending
R16.xml	Edgar Link	unprocessable
R17.htm	Edgar Link	pending
R17.xml	Edgar Link	unprocessable
R18.htm	Edgar Link	pending
R18.xml	Edgar Link	unprocessable
R19.htm	Edgar Link	pending
R19.xml	Edgar Link	unprocessable
R2.htm	Edgar Link	pending
R2.xml	Edgar Link	unprocessable
R20.htm	Edgar Link	pending
R20.xml	Edgar Link	unprocessable
R21.htm	Edgar Link	pending
R21.xml	Edgar Link	unprocessable
R22.htm	Edgar Link	pending
R22.xml	Edgar Link	unprocessable
R23.htm	Edgar Link	pending
R23.xml	Edgar Link	unprocessable
R24.htm	Edgar Link	pending
R24.xml	Edgar Link	unprocessable
R25.htm	Edgar Link	pending
R25.xml	Edgar Link	unprocessable
R26.htm	Edgar Link	pending
R26.xml	Edgar Link	unprocessable
R3.htm	Edgar Link	pending
R3.xml	Edgar Link	unprocessable
R4.htm	Edgar Link	pending
R4.xml	Edgar Link	unprocessable
R5.htm	Edgar Link	pending
R5.xml	Edgar Link	unprocessable
R6.htm	Edgar Link	pending
R6.xml	Edgar Link	unprocessable
R7.htm	Edgar Link	pending
R7.xml	Edgar Link	unprocessable
R8.htm	Edgar Link	pending
R8.xml	Edgar Link	unprocessable
R9.htm	Edgar Link	pending
R9.xml	Edgar Link	unprocessable
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
vstm-20130630.xml	Edgar Link	completed
vstm-20130630.xsd	Edgar Link	pending
vstm-20130630_cal.xml	Edgar Link	unprocessable
vstm-20130630_def.xml	Edgar Link	unprocessable
vstm-20130630_lab.xml	Edgar Link	unprocessable
vstm-20130630_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VSTM
Verastem, Inc. Stock $vstm

2013 Q3 Form 10-Q Financial Statement

#000104746913008394 Filed on August 13, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VSTM Verastem, Inc. Stock $vstm

2013 Q3 Form 10-Q Financial Statement

#000104746913008394 Filed on August 13, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VSTM
Verastem, Inc. Stock $vstm